Evidence map›Paper›PMID 40886289›Full record

ReviewAdvances in experimental medicine and biology2025

Circular RNAs in Immune-Related Diseases.

Maria Laura Idda, Antonella Francesca Fara, Matteo Floris

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maria Laura IddaDepartment of Biomedical Science, University of Sassari, Sassari, Italy. mlidda1@uniss.it.
Antonella Francesca FaraDepartment of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
Matteo FlorisDepartment of Biomedical Science, University of Sassari, Sassari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CircRNAs are a novel class of noncoding RNAs characterized by a covalently closed loop structure lacking both a 3' polyadenylation tail and a 5' cap. Increasing evidence demonstrated that circRNAs can participate in several biological processes including immune system physiology and immune-related diseases. CircRNAs act on immune pathways through several molecular mechanisms including miRNAs and RBP sponges, protein scaffolds, and mRNA stability modulation via diverse signaling pathways including MAPK, JAK-STAT, and Wnt signaling pathway. Recently, circRNAs have also been studied as biomarkers for immune diseases as well as new potential therapeutic targets. Effects of dysregulated circRNA levels correlate, among others, with alterations in immune cell behavior, cytokines production, and immune response in general.In this chapter, we describe new experimental progress in circRNAs that participates in the regulation of the immune system and in the pathogenesis of autoimmune diseases and infectious diseases.

Indexed as

Autoimmune DiseasesImmune System DiseasesRNA, CircularAnimalsBiomarkersGene Expression RegulationHumansMicroRNAsSignal TransductionBiomarkersMicroRNAsRNA, CircularAutoimmuneCircRNAImmune responseInfectious diseases

Identifiers

PMID40886289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.